Jefferies has upgraded Novo Nordisk (CSE:NOVOb) (NYSE:NVO) to Hold from Underperform, saying near-term downside risks have largely crystallized after sharp cuts to consensus estimates and a de-rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results